Citations (50)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (16)
Jovin J. Y. Choo, Christopher L. D. McMillan, Paul R. Young & David A. Muller. (2023) Microarray patches: scratching the surface of vaccine delivery. Expert Review of Vaccines 22:1, pages 937-955.
Read now
Read now
Pradip Kumar Yadav, Sanjoy Das & Malay K. Das. (2023) 3D-Microneedles: A novel approach for skin directed delivery and its application. Polymer-Plastics Technology and Materials 62:11, pages 1364-1393.
Read now
Read now
SeungHyun Park, KangJu Lee & WonHyoung Ryu. (2022) Research progress on detachable microneedles for advanced applications. Expert Opinion on Drug Delivery 19:9, pages 1115-1131.
Read now
Read now
Shanshan Zhou, Tianyu Ren, Hongjing Gu, Cheng Wang, Min Li, Zhongpeng Zhao, Li Xing, Liangyan Zhang, Yi Sun, Penghui Yang & Xiliang Wang. (2018) Intradermal delivery of a fractional dose of influenza H7N9 split vaccine elicits protective immunity in mice and rats. Human Vaccines & Immunotherapeutics 14:3, pages 623-629.
Read now
Read now
Ivan F. N. Hung & Kwok-Yung Yuen. (2018) Immunogenicity, safety and tolerability of intradermal influenza vaccines. Human Vaccines & Immunotherapeutics 14:3, pages 565-570.
Read now
Read now
Marc Demeulemeester, Nathalie Lavis, Yohan Balthazar, Patrice Lechien & Stéphane Heijmans. (2017) Rapid safety assessment of a seasonal intradermal trivalent influenza vaccine. Human Vaccines & Immunotherapeutics 13:4, pages 889-894.
Read now
Read now
Nicola Luigi Bragazzi, Andrea Orsi, Filippo Ansaldi, Roberto Gasparini & Giancarlo Icardi. (2016) Fluzone® intra-dermal (Intanza®/Istivac® Intra-dermal): An updated overview. Human Vaccines & Immunotherapeutics 12:10, pages 2616-2627.
Read now
Read now
Corwin A. Robertson, Peter Tsang, Victoria A. Landolfi & David P. Greenberg. (2016) Fluzone® Intradermal Quadrivalent Influenza Vaccine. Expert Review of Vaccines 15:10, pages 1245-1253.
Read now
Read now
Akihiko Saitoh & Yuta Aizawa. (2016) Intradermal vaccination for infants and children. Human Vaccines & Immunotherapeutics 12:9, pages 2447-2455.
Read now
Read now
Barbara Camilloni, Michela Basileo, Stefano Valente, Emilia Nunzi & Anna Maria Iorio. (2015) Immunogenicity of intramuscular MF59-adjuvanted and intradermal administered influenza enhanced vaccines in subjects aged over 60: A literature review. Human Vaccines & Immunotherapeutics 11:3, pages 553-563.
Read now
Read now
Harvinder S Gill, Sang-Moo Kang, Fu-Shi Quan & Richard W Compans. (2014) Cutaneous immunization: an evolving paradigm in influenza vaccines. Expert Opinion on Drug Delivery 11:4, pages 615-627.
Read now
Read now
Anto Vrdoljak. (2013) Review of recent literature on microneedle vaccine delivery technologies. Vaccine: Development and Therapy 3, pages 47-55.
Read now
Read now
Sang Hoon Han, Jun Hee Woo, Francoise Weber, Woo Joo Kim, Kyong Ran Peck, Sang Il Kim, Young Hwa Choi & June Myung Kim. (2013) Immunogenicity and safety of Intanza®/IDflu® intradermal influenza vaccine in South Korean adults: A multicenter, randomized trial. Human Vaccines & Immunotherapeutics 9:9, pages 1971-1977.
Read now
Read now
Orli Even-Or, Sarit Samira, Ronald Ellis, Eli Kedar & Yechezkel Barenholz. (2013) Adjuvanted influenza vaccines. Expert Review of Vaccines 12:9, pages 1095-1108.
Read now
Read now
Isabel Leroux-Roels & Françoise Weber. (2013) Intanza® 9 µg intradermal seasonal influenza vaccine for adults 18 to 59 years of age. Human Vaccines & Immunotherapeutics 9:1, pages 115-121.
Read now
Read now
Sang-Moo Kang, Jae-Min Song & Yeu-Chun Kim. (2012) Microneedle and mucosal delivery of influenza vaccines. Expert Review of Vaccines 11:5, pages 547-560.
Read now
Read now
Articles from other publishers (34)
Chiranjib Chakraborty, Manojit Bhattacharya & Sang-Soo Lee. (2023) Current Status of Microneedle Array Technology for Therapeutic Delivery: From Bench to Clinic. Molecular Biotechnology.
Crossref
Crossref
Junxia Wang, Ziyi Lu, Ruisi Cai, Hanqi Zheng, Jicheng Yu, Yuqi Zhang & Zhen Gu. (2023) Microneedle-based transdermal detection and sensing devices. Lab on a Chip 23:5, pages 869-887.
Crossref
Crossref
Abdulla Al Mamun & Feng Zhao. (2022) In-Plane Si Microneedles: Fabrication, Characterization, Modeling and Applications. Micromachines 13:5, pages 657.
Crossref
Crossref
Rayen Yanara Valdivia-Olivares, Maria Rodriguez-Fernandez, María Javiera Álvarez-Figueroa, Alexis M. Kalergis & José Vicente González-Aramundiz. (2021) The Importance of Nanocarrier Design and Composition for an Efficient Nanoparticle-Mediated Transdermal Vaccination. Vaccines 9:12, pages 1420.
Crossref
Crossref
Rigved Nagarkar, Mahima Singh, Hiep X. Nguyen & Sriramakamal Jonnalagadda. (2020) A review of recent advances in microneedle technology for transdermal drug delivery. Journal of Drug Delivery Science and Technology 59, pages 101923.
Crossref
Crossref
Johanna Hettinga & Robert Carlisle. (2020) Vaccination into the Dermal Compartment: Techniques, Challenges, and Prospects. Vaccines 8:3, pages 534.
Crossref
Crossref
Liping Xie, Hedele Zeng, Jianjun Sun & Wei Qian. (2020) Engineering Microneedles for Therapy and Diagnosis: A Survey. Micromachines 11:3, pages 271.
Crossref
Crossref
Akmal H. Sabri, Yujin Kim, Maria Marlow, David J. Scurr, Joel Segal, Ajay K. Banga, Leonid Kagan & Jong Bong Lee. (2020) Intradermal and transdermal drug delivery using microneedles – Fabrication, performance evaluation and application to lymphatic delivery. Advanced Drug Delivery Reviews 153, pages 195-215.
Crossref
Crossref
Eman M. Migdadi & Ryan F. Donnelly. 2019. Imaging Technologies and Transdermal Delivery in Skin Disorders. Imaging Technologies and Transdermal Delivery in Skin Disorders
223
270
.
Akmal H. Sabri, Jane Ogilvie, Khuriah Abdulhamid, Volha Shpadaruk, John McKenna, Joel Segal, David J. Scurr & Maria Marlow. (2019) Expanding the applications of microneedles in dermatology. European Journal of Pharmaceutics and Biopharmaceutics 140, pages 121-140.
Crossref
Crossref
Lipika Chablani, Suprita A. Tawde, Archana Akalkotkar & Martin J. D’Souza. (2019) Evaluation of a Particulate Breast Cancer Vaccine Delivered via Skin. The AAPS Journal 21:2.
Crossref
Crossref
Rubhan Chandran, Eusni Rahayu Mohd. Tohit, Johnson Stanslas & Tuan Mazlelaa Tuan Mahmood. 2019. Biomaterials and Bionanotechnology. Biomaterials and Bionanotechnology
495
525
.
Elena V. Vassilieva, Shelly Wang, Song Li, Mark R. Prausnitz & Richard W. Compans. (2017) Skin immunization by microneedle patch overcomes statin-induced suppression of immune responses to influenza vaccine. Scientific Reports 7:1.
Crossref
Crossref
N. Dang, T.Y. Liu & T.W. Prow. 2017. Micro and Nanotechnology in Vaccine Development. Micro and Nanotechnology in Vaccine Development
327
341
.
Robert L. Atmar & Wendy A. Keitel. (2016) Influenza Vaccination of Patients Receiving Statins: Where Do We Go From Here?. Journal of Infectious Diseases 213:8, pages 1211-1213.
Crossref
Crossref
Miyuki Tozuka, Tatsuya Oka, Nao Jounai, Gyohei Egawa, Ken J. Ishii, Kenji Kabashima & Fumihiko Takeshita. (2016) Efficient antigen delivery to the draining lymph nodes is a key component in the immunogenic pathway of the intradermal vaccine. Journal of Dermatological Science 82:1, pages 38-45.
Crossref
Crossref
Carlos A. DiazGranados, Corwin A. Robertson, H. Keipp Talbot, Victoria Landolfi, Andrew J. Dunning & David P. Greenberg. (2015) Prevention of serious events in adults 65 years of age or older: A comparison between high-dose and standard-dose inactivated influenza vaccines. Vaccine 33:38, pages 4988-4993.
Crossref
Crossref
Akihiko Saitoh, Yuta Aizawa, Isamu Sato, Harunobu Hirano, Takatsugu Sakai & Masaaki Mori. (2015) Skin thickness in young infants and adolescents: Applications for intradermal vaccination. Vaccine 33:29, pages 3384-3391.
Crossref
Crossref
T. Schaberg & M.W. Pletz. (2014) InfluenzaschutzimpfungInfluenza vaccination. Der Pneumologe 11:6, pages 493-499.
Crossref
Crossref
Carlos A. DiazGranados, Andrew J. Dunning, Murray Kimmel, Daniel Kirby, John Treanor, Avi Collins, Richard Pollak, Janet Christoff, John Earl, Victoria Landolfi, Earl Martin, Sanjay Gurunathan, Richard Nathan, David P. Greenberg, Nadia G. Tornieporth, Michael D. Decker & H. Keipp Talbot. (2014) Efficacy of High-Dose versus Standard-Dose Influenza Vaccine in Older Adults. New England Journal of Medicine 371:7, pages 635-645.
Crossref
Crossref
Peter Tsang, Geoffrey J. Gorse, Cynthia B. Strout, Malcolm Sperling, David P. Greenberg, Ayca Ozol-Godfrey, Carlos DiazGranados & Victoria Landolfi. (2014) Immunogenicity and safety of Fluzone® intradermal and high-dose influenza vaccines in older adults ≥65 years of age: A randomized, controlled, phase II trial. Vaccine 32:21, pages 2507-2517.
Crossref
Crossref
Satoshi Kashiwagi, Jianping Yuan, Benjamin Forbes, Mathew L. Hibert, Eugene L. Q. Lee, Laura Whicher, Calum Goudie, Yuan Yang, Tao Chen, Beth Edelblute, Brian Collette, Laurel Edington, James Trussler, Jean Nezivar, Pierre Leblanc, Roderick Bronson, Kosuke Tsukada, Makoto Suematsu, Jeffrey Dover, Timothy Brauns, Jeffrey Gelfand & Mark C. Poznansky. (2013) Near-Infrared Laser Adjuvant for Influenza Vaccine. PLoS ONE 8:12, pages e82899.
Crossref
Crossref
Pedro L. Moro, Theresa Harrington, Tom Shimabukuro, Maria Cano, Oidda I. Museru, David Menschik & Karen Broder. (2013) Adverse events after Fluzone® Intradermal vaccine reported to the Vaccine Adverse Event Reporting System (VAERS), 2011–2013. Vaccine 31:43, pages 4984-4987.
Crossref
Crossref
David Wing, Mark R. Prausnitz & Michael J. Buono. (2013) Skin pretreatment with microneedles prior to pilocarpine iontophoresis increases sweat production. Clinical Physiology and Functional Imaging, pages n/a-n/a.
Crossref
Crossref
Geoffrey J. Gorse, Ann R. Falsey, John A. Fling, Terry L. Poling, Cynthia B. Strout & Peter H. Tsang. (2013) Intradermally-administered influenza virus vaccine is safe and immunogenic in healthy adults 18–64 years of age. Vaccine 31:19, pages 2358-2365.
Crossref
Crossref
Anthony P. Raphael, Stefano C. Meliga, Xianfeng Chen, Germain J.P. Fernando, Christopher Flaim & Mark A.F. Kendall. (2013) Depth-resolved characterization of diffusion properties within and across minimally-perturbed skin layers. Journal of Controlled Release 166:2, pages 87-94.
Crossref
Crossref
Evelyna Derhovanessian, Heidi Theeten, Karin Hähnel, Pierre Van Damme, Nathalie Cools & Graham Pawelec. (2013) Cytomegalovirus-associated accumulation of late-differentiated CD4 T-cells correlates with poor humoral response to influenza vaccination. Vaccine 31:4, pages 685-690.
Crossref
Crossref
Bruce G. Weniger & Mark J. Papania. 2013. Vaccines. Vaccines
1200
1231
.
Angèle Soria, Annika Vogt, Adnan Nasir & Béhazine Combadière. 2013. Nanotechnology in Dermatology. Nanotechnology in Dermatology
165
178
.
Prathap Nagaraja Shastri, Min‐Chul Kim, Fu‐Shi Quan, Martin J. D'Souza & Sang‐Moo Kang. (2012) Immunogenicity and protection of oral influenza vaccines formulated into microparticles. Journal of Pharmaceutical Sciences 101:10, pages 3623-3635.
Crossref
Crossref
William C. Weldon, Vladimir G. Zarnitsyn, E. Stein Esser, Misha T. Taherbhai, Dimitrios G. Koutsonanos, Elena V. Vassilieva, Ioanna Skountzou, Mark R. Prausnitz & Richard W. Compans. (2012) Effect of Adjuvants on Responses to Skin Immunization by Microneedles Coated with Influenza Subunit Vaccine. PLoS ONE 7:7, pages e41501.
Crossref
Crossref
D. Kumar, E.A. Blumberg, L. Danziger-Isakov, C.N. Kotton, N.B. Halasa, M.G. Ison, R.K. Avery, M. Green, U.D. Allen, K.M. Edwards, G. Miller & M.G. Michaels. (2011) Influenza Vaccination in the Organ Transplant Recipient: Review and Summary Recommendations. American Journal of Transplantation 11:10, pages 2020-2030.
Crossref
Crossref
Peter Eizenberg, Robert Booy, Nadim Naser, Glen Mason, Daniel Stamboulian & Françoise Weber. (2011) Acceptance of Intanza® 9 μg intradermal influenza vaccine in routine clinical practice in Australia and Argentina. Advances in Therapy 28:8, pages 640-649.
Crossref
Crossref
Robert Arnou, Matthias Frank, Thomas Hagel & Alice Prébet. (2011) Willingness to vaccinate or get vaccinated with an intradermal seasonal influenza vaccine: a survey of general practitioners and the general public in France and Germany. Advances in Therapy 28:7, pages 555-565.
Crossref
Crossref